SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-17-126228
Filing Date
2017-04-17
Accepted
2017-04-17 17:28:05
Documents
6
Period of Report
2017-05-30

Document Format Files

Seq Description Document Type Size
1 PRE 14A d348433dpre14a.htm PRE 14A 476221
2 GRAPHIC g348433g84j48.jpg GRAPHIC 24647
3 GRAPHIC g348433g86y21.jpg GRAPHIC 41404
4 GRAPHIC g348433pc1.jpg GRAPHIC 15729
5 GRAPHIC g348433pc2.jpg GRAPHIC 15795
6 GRAPHIC g348433sig-new.jpg GRAPHIC 4165
  Complete submission text file 0001193125-17-126228.txt   618145
Mailing Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931
Business Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931 865-769-4011
PROVECTUS BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000315545 (see all company filings)

IRS No.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36457 | Film No.: 17765394
SIC: 2834 Pharmaceutical Preparations